Our findings, therefore, establish a novel c-MYC-assisted MALAT1-KTN1-EGFR axis, which contributes to cSCC development and may serve as novel target for therapeutic intervention. The gene discussed is MALAT1; the disease is skin squamous cell carcinoma.